Anavex completes patient enrolment for phase 2a Alzheimer’s trial
NEW YORK: Anavex Life Sciences Corp, a clinical-stage biopharmaceutical company developing drug candidates to treat…
FEATURED
New drug hope for ‘childhood Alzheimer’s’ after global trials
Charity now set to build new pods for homeless people
Lilly’s Alzheimer’s super drug to be approved ‘any day’
Pensioner with ‘severe dementia’ living in care home is prosecuted
Inquest begins after man took wife’s end-of-life medication
Surveys show public support on euthanasia for mentally ill
INNOVATION
